insights_auto
Bakit bumaba ang PGEN 2.18%?
Tingnan ang Higit pang Detalyechevron_right
PGEN:NASDAQ
Precigen Inc
$7.20
arrow_downward
-2.18%(-0.16) 1D
$7.23
arrow_upward
+0.49% (+0.035)todayPre-market
Sarado: Okt 15, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa PGEN...
Buksan
$7.31
Mataas
$7.55
Mababa
$7.17
Mkt. cap
2.58B
Avg. na dami
4.72M
Dami
303.00
Mataas nang 52-wk
$8.98
Mababa nang 52-wk
$3.04
EPS
-$1.10
Beta
0.92
Mga natitirang share
358.04M
Bilang ng mga empleyado
160
Buksan
$7.31
Mataas
$7.55
Mababa
$7.17
Mkt. cap
2.58B
Avg. na dami
4.72M
Dami
303.00
Mataas nang 52-wk
$8.98
Mababa nang 52-wk
$3.04
EPS
-$1.10
Beta
0.92
Mga natitirang share
358.04M
Bilang ng mga empleyado
160
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Reuters
·
12 oras ang nakalipas
S&P 500 ends higher as traders shift from AI to healthcare
MarketWatch
·
1 buwan ang nakalipas
The S&P 500 keeps climbing on days when stocks broadly struggle. Here’s what’s going on.
The Motley Fool
·
4 araw ang nakalipas
The S&P 500 Just Hit a Record High -- Here's How Much Higher It Can Climb, According to the Wall Street Consensus
TheStreet
·
1 buwan ang nakalipas
UBS revamps S&P 500 target for rest of 2026
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
Tungkol sa Precigen Inc